Abstract submissions are invited for HIV Drug Therapy Glasgow 2026. Accepted abstracts will be published as a supplement to the Journal of the International AIDS Society on Saturday 7 November 2026. 

The deadline to submit your abstract is Friday 26 June 2026, 23.59 PDT.

To support you in your submission, the following documents are available:

Abstract Submission Guidance and Categories

Abstract Terms and Conditions

HIV Drug Therapy Glasgow is committed to the People First Charter and strongly recommends the use of inclusive language in abstracts. A full list of recommended terminology is available via the link.

HIV Drug Therapy Glasgow is a gender-inclusive meeting. Authors are encouraged to use appropriate gender‑inclusive language as described in the United Nations guidelines.

For general questions regarding submission, on-site requirements, embargo, and copyright please see the Congress abstract FAQ document.

All abstracts submitted to the Congress will be reviewed by the Scientific Committee. Outcome notifications will be sent to the submitter by Monday 14 September 2026.If you have not received a notification email by this date, please contact the Congress Secretariat at hivglasgow@ashfieldmedcomms.com, quoting the reference number issued upon submission.

Late Breakers

To be eligible to submit a late breaker abstract, a letter of intent must be submitted to the Congress Secretariat at hivglasgow@ashfieldmedcomms.com by the regular abstract submission deadline of Friday 26 June 2026, 23:59 PDT. The letter of intent should include the working title of the late breaker abstract, a short summary, and the reason for the late breaker request.

Following acceptance of the late breaker request, you will receive a bespoke submission link to enable you to populate your late breaker abstract. The late breaker submission deadline is Friday 21 August 2026, 23:59 PDT.